Bioavailability of DHE Administered by I123 POD Device, IV Injection, and Migranal Nasal Spray in Healthy Adults

NCT03401346 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Migraine Headache

Interventions

COMBINATION_PRODUCT: INP104
DRUG: Dihydroergotamine Mesylate (DHE)
COMBINATION_PRODUCT: Migranal Nasal Spray

Sponsor

Impel Pharmaceuticals